A virus-specified polypeptide of 160000 mol. wt. (160K)was purified more than 1000-fold from the soluble proteins present in the culture medium of cells productively infected with herpesvirus saimiri (HVS). Purified preparations of the 160K polypeptide gave rise to high titre precipitating and neutralizing antibodies in immunized rabbits, which cross-neutralized independent isolates of HVS (neutralization rate constants, k, of between 3-8 and 4.8) and specifically precipitated the 160K polypeptide from extracts of cells infected with the homologous or heterologous strains of this virus. Antiserum to the 160K polypeptide of HVS also gave low (k = 0.02) levels of neutralization of the related herpesvirus ateles. Purified preparations of the 160K polypeptide were capable of removing most or all of the neutralizing antibody sera of squirrel monkeys with naturally acquired antibodies to HVS. The 160K polypeptide was previously shown to form part of the surface of enveloped virus particles. However, we show here that the 160K polypeptide is not extensively glycosylated in infected cells. The majority of glucosamine incorporation specific to HVS-infected cells was into eight regions with apparent mol. wt. of 170K to 220K, 125K to 145K, l15K to 120K, 83K to 88K, 65K to 75K, 52K to 58K, 25K to 27K and 12.5K to 13K. It remains possible that alternative cleaved or glycosylated forms of the 160K polypeptide are also present on the virus particle or that precipitating antibody to 160K and virus-neutralizing antibodies are not identical. However, our inability to detect precipitating antibody to virus-induced proteins or glycoproteins other than the 160K polypeptide and the high titre of neutralizing antibody present in this serum, provides reasonable evidence that it is the antibodies which react with the 160K polypeptide that are responsible for virus neutralization.
INTRODUCTION
Herpesvirus saimiri (HVS) and herpesvirus ateles (HVA) are related viruses which naturally infect squirrel (Saimiri sciureus) and spider (Ateles sp.) monkeys respectively. In their natural host species these viruses establish latent or persistent infections with no overt disease. However, others have reported that infections with these viruses cause rapidly fatal lymphoproliferative disease in a number of other species of New World primates (e.g. 'cotton top' and 'common' marmosets; for reviews, see Deinhardt, 1973; Fleckenstein, 1979) .
We previously reported that two polypeptides with mol. wt. of 160 000 and 28 000 (160K and 28K) were the major virus-specific polypeptides released in a soluble form into the culture medium of owl monkey kidney cells productively infected with HVS. We also presented evidence that the 160K polypeptide was a component of the virus envelope and suggested 0022-1317/82/0000-4846 $02.00 © 1982 SGM that virus-specified polypeptides in the culture medium of HVS-infected cells should provide ideal starting materials for the purification and antigenic analysis of protein components of the virus envelope (Randall & Honess, 1980) . In this paper we report on a simple procedure for the purification of the 160K polypeptide from the culture medium of cells productively infected with HVS. We show here that the purified preparation of the 160K polypeptide elicits virus-neutralizing and precipitating antibody in immunized rabbits. We also present results from the use of this specific antibody to the 160K polypeptide to analyse antigenic cross-reactions between strains of HVS and HVA, and the relationship of the 160K polypeptide to virus-induced glycoproteins in cells infected with HVS.
METHODS

Cells and Viruses.
A continuous line of owl monkey kidney cells (OMK-210, kindly provided by Drs L. V. Melendez and M. D. Daniels, New England Regional Primate Center, Southborough, Boston, Mass., U.S.A. or Professor M. A. Epstein, The Medical School, Bristol, U.K.) was used throughout for virus growth and infectivity titrations. Uninfected cells were propagated at 37 °C in Dulbecco's modification of Eagle's medium containing 10% calf serum. The attenuated derivative of HVS strain 11 (HVS[ l 1 Atth Schaffer et al., 1975) was used as the prototype strain for most of the experiments reported in this paper. In addition, HVS strains SMH1 (Daniel et al., 1976) , HOT (Hunt et al., 1973) , KM 744 (isolated by Professor K. McCarthy, The Medical School, Liverpool, U.K.) and 87 (provided by H. Wolf and G. Bayliss, Pettenkofer Institute, Munich, F.R.G.), and HVA strain 73 (Falk et al., 1974) , were included in some comparative studies, HVS strains HOT and KM 744 have recently been renamed OMI and 22 respectively (L. A. Falk et al., personal communication) . Herpes simplex virus type 1 (HSV-1) strain HFEM/STH2 was used throughout as a prototype HSV-1 strain for studies of virus neutralization and comparative analyses of virus-induced proteins and glycoproteins.
Production and radioactive labelling of proteins released from productively infected tissue culture cells. Monolayers of OMK-210 cells in 80 oz Winchester bottles were infected with 0.05 to 0.2 p.f.u./cell of HVS[ll Att]. When 10 to 20% of cells showed a virus-specific cytopathic effect (c.p.e.), the growth medium was replaced with 50ml Dulbecco's modification of Eagle's medium lacking calf serum and containing 1/10 (i.e. 1.5 mg/1) of the normal concentration of unlabelled methionine with 2 gCi/ml [35S]methionine (500 Ci/mmol; Amersham International). Cultures were re-incubated until 90 to 100% of the cells showed a c.p.e. (a further 24 to 36 h at 37 °C). The culture medium was thei~ collected and centrifuged (3000 rev/min for 10 min) to sediment cells and large cellular debris. The supernatant was removed and centrifuged at 14000 rev/min in a 6 × 100 ml rotor of an MSE high speed 18 centrifuge for 2 h to sediment virus and other particulate material into a pellet, Soluble proteins in the supernatant were precipitated by adding an equal volume of neutral saturated ammonium sulphate. After incubation overnight at 4 °C the precipitate was sedimented (10000 rev/min for 15 min) and the pellet redissolved in phosphate-buffered saline (PBS) (approx. 1 x l0 s cell equivalents/ml) and dialysed against the same buffer to remove any traces of ammonium sulphate.
Infection of cultures at high multiplicity for analysis of [aSS]methionine and [14C]-glucosamine incorporation into virus-induced polypeptides and preparation of labelled virus antigens.
Monolayers of OMK-210 cells in fiat-sided disposable plastic tissue culture tubes (1 x 106 cells/tube, Nunc) or in 75 cm 2 flats (1 × 107 to 2 × 107 cells/flat), were mock-infected or infected with either 5 to 10 p.f.u./cell of HVS[ I 1 Att] or with 5 to 10 p.f.u./cell of HSV-1 (strain HFEM/STH2). After adsorption for 2 h the inoculum was removed and the cells reincubated at 37 °C in medium supplemented with 2% calf serum. Cells were labelled, at various times and for intervals given in the text, by replacing the culture medium with either glucosamine (0-6 pCi/ml; Amersham International) and 1% calf serum. At the end of the labelling period the cells were washed twice with ice-cold PBS. Cell samples for polypeptide analysis were solubilized in disruption buffer (2 % SDS, 5 % fl-mercaptoethanol, 0-05 M-tris-HC1 pH 7 and 3 % glycerol; 1 x 10 6 cells/0.75 ml), prior to electrophoresis through SDS-polyacrylamide gels. Infected culture cells used for preparing labelled antigen fractions were resuspended in PBS (1 x 107 to 2 x 107 cells/ml). These cells were then either disrupted by ultrasonic oscillation, centrifuged at 35000 rev/min for 1 h in an MSE 6 × 5.5 ml swing-out rotor and the supernatants (total cell soluble antigen fraction) collected; or were disrupted with seven strokes of a Dounce homogenizer with a B grade pestle, before the nuclei and large membrane fractions were sedimented by centrifugation (3500 rev/min for 15 rain). Pellets were resuspended in 1% Nonidet P40 (NP40) in PBS (1.2 × 107 cells/ml) by brief treatment with an ultrasonic probe, left for 30 rain at 4 °C and centrifuged at 30000 rev/min for 1 h in an MSE 6 x 5.5 ml swing-out rotor. The supernatants (NP40-solubilized fractions) were collected and used in immune precipitation studies as were total cell soluble antigen fractions.
Antisera. Antiserum to the 160K polypeptide specified by HVS (anti-160K antiserum) was prepared by repeated (five times) intramuscular injections of Sandy Lop rabbits, at 2 to 3 weekly intervals, with a purified preparation of the 160K polypeptide in complete Freund's adjuvant. A total of approx. 2 mg of the 160K polypeptide was used to immunize rabbits. The preparation and properties of an antiserum which was raised to a virus polypeptide with estimated tool. wt. of 30000 (30K, anti-30K antiserum) will be reported elsewhere. This antiserum while reacting with the 30K virus polypeptide also reacts with the 28K polypeptide released into the culture medium of HVS-infected cells (R. E. Randall & R. W. Honess, unpublished results). Squirrel monkey sera consisted of pooled sera from animals with naturally acquired immunity and neutralizing antibodies to HVS.
Immunodiffusion and immune precipitation. Agar gel immunodiffusion tests were performed in 2 to 3 mm layers of 1% agar in which dilutions of antigen were diffused against dilutions of antisera. In immune precipitation tests, various antigen fractions were incubated with differing amounts of sera (for details see text) in 2 ml plastic conical tubes, for 18 to 24 h at 4 °C. Immune complexes that formed were sedimented into pellets by centrifugation at 10000 rev/min for 10 min. The supernatant fluids were removed and the pellets washed twice with ice-cold PBS. The pellets were then resuspended in a small volume (0.12 ml) of disruption buffer and the polypeptides separated by SDS-polyacrylamide gel electrophoresis.
Neutralization tests. Virus (4 x 104 p.f.u./ml) was incubated at 25 °C for 2 h with an equal volume of antiserum, diluted where necessary, and surviving virus was assayed by plaque assays on preformed monolayers of OMK-210 cells. Results are expressed either as the percentage survival of infectious virus after incubation with immune sera (V), compared to the number surviving incubation with preimmune sera (V0), i.e. V/V o x 100; or in terms of neutralization rate constants (k), i.e. Polyacrylamide gel electrophoresis and quantification of electrophoretically separated polypeptides. The procedures for sample preparation and electrophoresis through SDSpolyacrylamide slab gels, and for the fixing, staining and autoradiography of these gels were as described previously (Heine et al., 1974) . The contribution of individual polypeptides to the total protein and labelled protein content of samples was quantified by using a Joyce-Loebl scanning microdensitometer to make absorbance tracing of negative films of the photographed Coomassie Brilliant Blue-stained gel films (total protein) and of the autoradiographic images (labelled proteins) of electrophoretically separated polypeptides. HVS polypeptides are referred to in terms of their tool. wt. as estimated by SDSpolyacrylamide gel electrophoresis, while we classify the polypeptides and glycoproteins of HSV by the nomenclatures of Honess & Roizman (1973) and Spear (1976) respectively.
RESULTS
We previously documented the preferential release of virus-induced polypeptides of 160000 and 28000 (160K and 28K) in a soluble form into the culture medium of infected cells. Whilst this preferential release results in a significant enrichment of these components with respect to cellular proteins and other virus-induced polypeptides, the culture fluid nonetheless contains many other soluble protein species derived both from the uninfected cell and serum proteins of the culture medium. Fig. 1 illustrates the contrast between the relative simplicity of the virus-induced polypeptides in the medium of infected cells (autoradiogram slot 2) with the complexity of proteins released from uninfected cells (autoradiogram slot 1) and the total protein content of medium proteins of infected and uninfected cells (Coomassie Brilliant Blue-stained gel film, slots 1 and 2). However, preliminary experiments showed that the 160K polypeptide could be purified by a relatively simple two-step procedure from the complex mixture of proteins precipitated from the medium of infected cells by 50% ammonium sulphate.
The first step in the procedure took advantage of the differential solubility of the 160K polypeptide and the majority of serum proteins in phosphate buffer at pH 5.8. The proteins precipitated by ammonium sulphate from the culture medium of infected cells were dissolved and dialysed against PBS. This soluble protein preparation was then dialysed exhaustively against 0.05 M-phosphate buffer pH 5.8 at 4 °C, whereupon a precipitate formed which contained less than 20% of the total protein of the original suspension. Analysis of the proteins soluble and insoluble in 0.05 M-phosphate buffer pH 5.8 ( Fig. 1 slots 3 and 4) showed that whereas the majority of serum proteins remained soluble, greater than 75 % of the 160K polypeptide from the original suspension was precipitated under these conditions. Similarly, many unlabelled proteins characteristic of the uninfected cell were efficiently precipitated during dialysis against low molarity buffer pH 5.8. The second step in the purification was fractionation of proteins that were insoluble in low ionic strength at pH 5.8, by ion-exchange chromatography on a column of carboxymethylcellulose equilibrated with 0.05 M-phosphate buffer pH 5.8. Proteins were eluted from the column by stepwise additions of 0.05 M-, 0.i M-and 1 M-NaC1 in 0-05 M-phosphate buffer pH 5-8 (Fig. 2) . The majority of proteins loaded on to the column either failed to bind (Fig. 2 , fractions 6 to 12), or were retained by the column. The major peak of post-infection label was eluted with a minor protein peak by 1 M-NaC1. Analysis of the total and labelled polypeptide populations from these fractions (Fig. 1 , slots 5 to 9 and Fig. 3, slots 3) showed that the major component of fractions eluted with 1 M-NaC1 was the 160K polypeptide, although trace amounts of other labelled proteins and certain cellular proteins were occasionally detected (compare Fig. 1 , slots 8 with Fig. 3, slots 3 ). Quantitative analysis of absorbance tracings from separated polypeptides showed the 160K polypeptide constituted at least 70% of the post-infection label, and greater than 60% of the total protein content, eluted by 1 M-NaC1. Approx. 30% of the 160K polypeptide loaded on to the column was recovered in the 1 M peak fractions. This purification procedure resulted in about 23 % overall recovery of the 160K polypeptide from the original culture medium, with greater than 1000-fold purification with respect to the total protein content of the medium. 
Production and properties of antibodies to the 160K polypeptide
Immunodiffusion and immunoprecipitation
Preparations o f the 160K polypeptide were purified from the culture medium as described above. Validation o f the purity o f these preparations is presented in Fig. 3 . After five 154 (a) 160... inoculations with a total of 0.2 mg of the purified 160K polypeptide (Fig. 3, slots 3) sera from immunized rabbits were tested by gel radial immunodiffusion and radioimmune precipitation against extracts of infected and uninfected cells and the tissue culture medium from these cells. In immunodiffusion tests the antiserum gave a number of precipitin lines when diffused against the culture medium from infected cells (Fig. 4a) . Prior absorption of the antiserum with serum components and extracts of uninfected cells gave a serum with a high titre of a single surviving precipitating activity which was specific for extracts of infected cells (Fig. 4 b) . The specificity of antiserum to 160K polypeptide was also analysed by comparing the percentage of labelled protein precipitated from lysates of cells infected with HSV, HVS or mock-infected cells, after incubation with antiserum to 160K polypeptide, anti-HSV-1 antiserum and preimmune rabbit serum (Table 1) . Antiserum to the 160K polypeptide precipitated 5 % of labelled proteins from the soluble antigen fraction of cells infected with HVS, compared to 0 . 3 % and 0 . 3 8 % precipitated by preimmune and anti HSV-1 sera respectively. In addition, antiserum to 160K polypeptide did not precipitate a significantly Antiserum Preimmune Anti-160 Anti-HSV 1 * Samples from Table 1 . greater percentage of counts than did preimmune serum from lysates of cells infected with HSV or mock-infected cells. Similarly, anti-HSV-1 antiserum showed no specific reaction against HVS or mock-infected cell lysates. Gel electrophoresis of the proteins present in these immune precipitates did not demonstrate specific precipitation of any virus-induced polypeptides by antisera to the heterologous virus (data not shown). Qualitative analysis of polypeptides represented in immune precipitates formed with anti-160K antibody and HVS-infected cells readily demonstrated highly specific and efficient precipitation of the 160K polypeptide; Fig. 5 shows the result from a typical analysis. Aliquots of soluble antigen fractions from lysates of cells infected with HVS and mock-infected cells (4 x 107 cell equivalents/ml) were incubated with a range of volumes of preimmune serum and anti-160K antiserum, both before and after absorption with an excess of proteins from calf serum and uninfected cells. Samples of the resulting immune precipitates were separated by electrophoresis on a polyacrylamide slab gel (Fig. 5) . A few minor polypeptides were non-specifically represented in immune and preimmune precipitates from uninfected cells (Fig. 5 , slots 8 to 10); in addition, trace amounts of two proteins specifically precipitated from uninfected cells by anti-160K antiserum were removed by the absorption (compare slots 8 and 9, components marked h). However, the absorbed anti-160K antibody specifically and quantitatively precipitated the single virus-specified polypeptide of 160K from the soluble antigen fraction of HVS-infected cells (slots 5 and 6). These experiments showed that the only detectable reaction against virus-specified polypeptides of anti-160K antiserum was against the 160K polypeptide and that the serum could be rendered specific for this component by absorption to remove minor contaminating antibodies against components of calf serum and uninfected cells. The anti-160K antibody was directed against the polypeptide from the culture medium of cells infected with the attenuated derivative of HVS[11 Att]. Absorbed anti-160K antiserum gave a single precipitin line (i.e. a reaction of antigenic identity) when diffused against intracellular proteins from a lysate of infected cells and proteins in the culture medium from infected cells in adjacent wells of the radial immunodiffusion plate (Fig. 6a) . Fig. 6 (a) also illustrates that the reaction with anti-160K antiserum is distinct (i.e. the precipitin lines cross) from that observed between an antiserum which reacts with the 28K polypeptide present in the culture medium of infected cells (anti-30K antiserum; R. E. Randall et al., unpublished Mol. wt. x 10 -3 methionine-labelled polypeptides, separated by electrophoresis through a 10% polyacrylamide slab gel from: lysate of mock-infected (slot 1) and HVS-infected (slot 2) OMK cells and the total cell soluble antigen from these cells (slots 3 and 4 respectively); immune precipitates formed during the incubation of infected total cell soluble antigen (0.2 ml) with absorbed anti-160K antiserum (0.1 and 0-2 ml, slots 5 and 6 respectively) and with preimmune serum (0.2 ml, slot 7). Also shown are the labelled polypeptides precipitated from the total cell soluble antigen of uninfected cells (0.2 ml) during incubation with absorbed (0.2 ml, slot 8) and unabsorbed (0.2 ml, slot 9) anti-160K antiserum, and with preimmune serum (0.2 ml, slot 10). Cells were labelled with PSS]methionine from 24 h to 36 h after mock infection or infection with HVS[ 11 Att]. * Dilutions of sera were incubated with equal volumes of antigen fractions (see Fig. 3 , slot 3), left for 18 h at 4 °C, heat-inactivated at 56 °C and tested for residual neutralizing activity. results). Fig. 6 (b) shows the reaction of anti-160K antibody with extracts from cells infected with the homologous virus and with four independent isolates of HVS. An identical precipitin line was seen in the reaction with all five viruses.
HVS protein that elicits neutralizing antibody Specificity of immune precipitation by anti-160K antibody*
R. E. R A N D A L L A N D R. W. H O N E S
(b)
The ability of rabbit anti-160K antibody to neutralize the infectivity of homologous and heterologous strains of HVS and the related HVA was tested in a series of plaque-reduction tests. Anti-160K antiserum neutralized all four strains of HVS with similar efficiency with rate constants for neutralization (k) of 3.6 to 4.8. In contrast, the lowest dilution of serum tested (1/2) failed to neutralize more than 70% of the infectivity of HVA, giving an estimate for the ratio of neutralization constants for HVS and HVA (4.8/0.02, Table 2 ) of about 240: 1. However, this cross-neutralization is significant as judged against a negative control, HSV. Anti-30K antiserum showed no significant neutralization (> 90% survival with 1/2 dilution of serum) against homologous or heterologous viruses.
Squirrel monkeys persistently infected with HVS have variable titres of naturally acquired neutralizing antibody directed against the virus. The ability of the 160K polypeptide to remove this antibody was therefore tested. For this experiment a preparation of the 160K polypeptide purified by ion-exchange chromatography (i.e. Fig. 3, slot 3 ) and buffer controls without 160K protein, were mixed with dilutions of pooled sera from naturally immune squirrel monkeys and with dilutions of rabbit anti-160K serum. After incubation of these mixtures (overnight at 4 °C) the residual neutralizing activity was measured in a plaque-reduction test against HVS[11 Att] ( Table 3 ). The purified polypeptide was capable of removing most or all of the neutralizing activity of the squirrel monkey serum and the rabbit anti-160K antiserum (column 1, Table 3 ). 
Identification of virus-induced glycoproteins and analysis of the glycosylation status of the 160K polypeptide in infected cells
In the case of HSV and most other enveloped virus particles, the envelope polypeptides which react with neutralizing antibody are extensively glycosylated in the virus particle, in membranes of infected cells and when excreted into the culture medium (see e.g. Spear & Roizman, 1972; Heine et al., 1974; Powell et al., 1974; . It therefore seemed relevant to identify virus-induced changes in the populations of infected cell glycoproteins and to examine the glycosylation status of the 160K polypeptide. A total of ten proteins unique to the infected cell incorporated label from a [14C]glucosamine precursor (Fig. 7) . The majority of glucosamine incorporation specific to the infected cell was into six regions with apparent tool. wt. of 170K to 220K, 125K to 145K, l 1 5 K to 120K, 83K to 88K, 65K to 75K and 52K to 58K. Proteins in all six of these major regions, and minor species of 25K to 27K and 12-5K to 13K mol. wt., were characterized by a relatively high ratio of 
159
[35Slmethionine incorporation being similar for the 150K and 160K polypeptides (Fig. 7) . We will show elsewhere that the 150K polypeptide is the major capsid protein of HVS. Moreover, cells infected with HSV, when labelled under the same conditions, incorporated similar amounts of [~4C]glucosamine-derived radioactivity into the major capsid protein of the virus (VP5; not shown). Thus, these results clearly show that either the 160K polypeptide is not glycosylated or that it is only poorly glycosylated. The above analysis of glycosylated species specific to infected cells showed that for highly glycosylated species a [~4C]glucosamine label was a more sensitive method for their detection than [35S]methionine label. To determine whether anti-160K antiserum had high titre antibodies which reacted with the major virus-specified glycoproteins, anti-160K antiserum was incubated (overnight at 4 °C) with a soluble antigen fraction of cells infected with HVS, in which the glycoproteins had been radioactively labelled with [~4CIglucosamine. The proteins present in the resulting precipitates were separated by polyacrylamide slab gel electrophoresis (Fig. 8) . The 160K polypeptide was quantitatively precipitated (Fig. 8 , stained gel film, compare samples 2 P and 3 P); however, whilst all major virus glycoproteins were readily detected in the input antigen preparation (Fig. 8, autoradiogram, 2 A) , the only glucosamine label detected in the anti-160K immune precipitate was associated with the 160K polypeptide band (Fig. 8. sample 3 A) . In view of the large difference in the ratio of glucosamine/methionine incorporation into the 160K polypeptide and the major virus glycoproteins, this result reflects a high degree of discrimination against the precipitation of highly glycosylated proteins by anti-160K antiserum.
DISCUSSION
The procedure reported in this paper for purifying the 160K polypeptide resulted in more than 1000-fold purification of the 160K polypeptide with respect to the total protein content of the culture medium of infected cells and in fractions being obtained in which the 160K polypeptide constituted greater than 60% of the total protein content as judged by SDS gel electrophoresis (Fig. 1, slot 8; Fig. 3, slot 3) . Antiserum raised to this preparation of the 160K polypeptide had high titres of both precipitating antibody and of neutralizing antibody. This antiserum immune-precipitated the 160K polypeptides from cells infected with heterologous strains of HVS (Fig. 6b) and cross-neutralized these strains of virus with comparable efficiency (Table 2 ). Unlike previous reports, which failed to demonstrate any cross-neutralization between HVS and HVA (Melendez et al., 1972; Deinhardt, 1973) , antiserum raised to the 160K polypeptide of HVS[11 Att] showed low, but significant, neutralizing activity against HVA strain 73. The ratio of the neutralization rate constants of anti-160K antiserum against HVS[ 11 Att] (kuv s = 4-8) relative to HVA (kav A = 0.02), i.e. knvs/kHv A, was 240. An apparently analogous virus-induced polypeptide of 160K has been identified in cells infected with HVA (R. W. Honess, unpublished observations) and there is a high degree of DNA homology (35 %) between HVA and HVS (Fleckenstein et al., 1978) . However, the antigenic relatedness of these two viruses, as measured by this crossneutralization, is less than that reported between HSV and a number of related herpesviruses, such as B virus, SA8, canine herpes and bovine mammillitis virus (for review, see Honess & Watson, 1977) .
Studies on the glycosylation status of the 160K polypeptide in the infected cells showed that either the 160K polypeptide was not glycosylated or was very poorly glycosylated. The low glycosylation status of the 160K polypeptide was unexpected as proteins that form the target sites for antibody-mediated virus neutralization of other herpes viruses are extensively glycosylated (Honess & Watson, 1974; PoweU et al., 1974; Hoffman et al., 1980; Thorley-Lawson & Geilinger, 1980) . Anti-160K antiserum had antibodies against serum and two uninfected cell proteins ( Fig. 4a; Fig. 5, slot 9 ), which must have been minor contaminants of the 160K polypeptide used to immunize rabbits (Fig. 3, slot 3) . It is therefore possible that a minor antibody population was responsible for the neutralizing activity of anti-160K antiserum. However, the inability to detect precipitation of any other virus-induced proteins or glycoproteins by anti-160K antiserum and its high titre of neutralizing antibodies provide good evidence that antibodies directed against the 160K polypeptide, or processed forms of this polypcptide unique to the virus particle, neutralize virus infectivity.
